QRG Capital Management’s Genmab GMAB Stock Holding History

QRG Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Buy	72,643 +6,821	+10%	+$181K	0.02%	466
2026 Q1	$1.77M	Buy	65,822 +4,561	+7%	+$137K	0.02%	447
2025 Q4	$1.89M	Buy	61,261 +6,149	+11%	+$192K	0.02%	419
2025 Q3	$1.69M	Sell	55,112 -10,790	-16%	-$263K	0.02%	415
2025 Q2	$1.36M	Sell	65,902 -8,945	-12%	-$184K	0.01%	541
2025 Q1	$1.47M	Buy	74,847 +50,990	+214%	+$1.07M	0.02%	513
2024 Q4	$498K	Sell	23,857 -5,579	-19%	-$123K	0.01%	766
2024 Q3	$718K	Sell	29,436 -1,037	-3%	-$27.7K	0.01%	676
2024 Q2	$766K	Sell	30,473 -6,046	-17%	-$171K	0.01%	608
2024 Q1	$1.09M	Sell	36,519 -34,633	-49%	-$1.02M	0.01%	531
2023 Q4	$2.27M	Sell	71,152 -8,236	-10%	-$259K	0.03%	376
2023 Q3	$2.8M	Buy	+79,388	New	+$3.03M	0.05%	320

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

QRG Capital Management's GMAB Position: Q2 2026 in Review

QRG Capital Management increased its Genmab (GMAB) stake by 10% in Q2 2026, buying an estimated $181K and bringing the position to 72,643 shares worth $2M. The position accounts for 0.02% of the portfolio, ranked #466.

QRG Capital Management first reported a position in GMAB in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.8M in Q3 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

QRG Capital Management held 72,643 shares of Genmab worth $2M as of Q2 2026.
QRG Capital Management bought 6,821 Genmab shares in Q2 2026, an estimated $181K.
Genmab made up 0.02% of QRG Capital Management's portfolio in Q2 2026, its #466 holding.
QRG Capital Management first reported a position in Genmab in Q3 2023 and has held it in 12 quarters since.
QRG Capital Management's Genmab position peaked at $2.8M in Q3 2023.
289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.